Innovating Works

NANOIMMUNOTECH

Inactiva
SUSPENCE: SUSPension ENvironment for CEll culture BIOCOM BIOMEDICAL COMPONENTS SRL tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Large-scale production of cells is essential for basic research, disease modelling and drug testing. However, scalability and standardizatio...
2019-05-06 - 2019-11-30 | Financiado
NanoTBTech: Nanoparticles based 2D thermal bioimaging technologies UNIVERSIDADE DE AVEIRO tramitó un H2020: H2020-FETOPEN-2016-2017 Temperature measurements are crucial in countless technological developments, accounting for 80% of the sensor market throughout the world....
2018-05-04 - 2022-02-28 | Financiado
NEW DEAL: New siRNA Nanotherapy for Inflammatory Bowel Diseases targeting Janus kinases COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES tramitó un H2020: H2020-NMBP-2016-2017 Inflammatory bowel diseases (IBD) are the second most common immune-mediated disorders in Europe, affecting more particularly young people....
2016-11-09 - 2021-09-30 | Financiado
HEATSENS_S: Lab on a chip microfluidic device based on plasmonic driven thermal nanobiosensing for rapid detect... NANOIMMUNOTECH tramitó un H2020: H2020-SMEInst-2016-2017 NANOIMMUNOTECH (NIT) is a nanobiotechnology Company which is the sole exploiter of an exclusive ultrasensitive biosensor nanotechnology, cal...
2016-09-06 - 2019-02-28 | Financiado
BIOCAPAN: BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES tramitó un H2020: H2020-NMP-2014-2015 The key therapeutic issue in diabetes mellitus type I and II is glycaemic control. Reductions of constant self-control, of insulin injection...
2015-05-29 - 2019-09-30 | Financiado
HEATSENS_S: Lab on a chip microfluidic device based on plasmonicdriven thermal sensing for rapid detection of Sa... NANOIMMUNOTECH tramitó un H2020: H2020-SMEInst-2014-2015 NANOIMMUNOTECH (NIT), a leading company in nanobiotechnology with know-how that has been applied to the field of nanobiosensing and especial...
2015-04-16 - 2015-10-31 | Financiado
MARISURF: NOVEL SUSTAINABLE MARINE BIO SURFACTANT BIO EMULSIFIERS FOR COMMERCIAL EXPLOITATION HERIOTWATT UNIVERSITY tramitó un H2020: H2020-BG-2014-2015 Surfactants and emulsifiers constitute an important class of chemical agents that are widely used in almost every sector of modern industry....
2015-02-18 - 2021-02-28 | Financiado
NAREB: Nanotherapeutics for antibiotic resistant emerging bacterial pathogens INSTITUT PASTEUR tramitó un FP7: Increase in antibiotic resistance is a global concern worldwide. The project NAREB's main objective is the optimization of several nanoformu...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.